|
CDCA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.6230000005345E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.113880E-02 |
| Normal-vs-Stage2 |
1.898640E-01 |
| Normal-vs-Stage3 |
1.489620E-02 |
| Normal-vs-Stage4 |
5.454000E-02 |
| Stage1-vs-Stage2 |
5.449000E-01 |
| Stage1-vs-Stage3 |
8.822400E-02 |
| Stage1-vs-Stage4 |
3.093000E-01 |
| Stage2-vs-Stage3 |
4.396600E-01 |
| Stage2-vs-Stage4 |
7.903200E-01 |
| Stage3-vs-Stage4 |
5.853800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59370000000414E-05 |
| Normal-vs-AfricanAmerican |
4.178000E-04 |
| Normal-vs-Asian |
6.072300E-02 |
| Caucasian-vs-AfricanAmerican |
2.417800E-02 |
| Caucasian-vs-Asian |
6.086800E-01 |
| AfricanAmerican-vs-Asian |
3.065800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.954910E-04 |
| Normal-vs-Female |
1.98856999999997E-05 |
| Male-vs-Female |
5.178800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.296500E-03 |
| Normal-vs-Extreme_Weight |
2.802300E-02 |
| Normal-vs-Obese |
1.732310E-02 |
| Normal-vs-Extreme_Obese |
1.973820E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.988400E-01 |
| Normal_Weight-vs-Obese |
3.985200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.073700E-02 |
| Extreme_Weight-vs-Obese |
4.334800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.157610E-01 |
| Obese-vs-Extreme_Obese |
4.819900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.759500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.006800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.06140000000144E-05 |
| Normal-vs-Age(81-100Yrs) |
2.309700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.123000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.069500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.269700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.186150E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.424300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.092400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.771600E-04 |
| Normal-VS-Type2 PRCC |
2.923700E-03 |
| Normal-VS-KIRP CIMP |
2.578500E-03 |
| Normal-VS-Unclassified PRCC |
3.70240000000521E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.020000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.000200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.066200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.179000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.464300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.521900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.200400E-02 |
| Normal-vs-N1 |
4.26780000000182E-05 |
| Normal-vs-N2 |
5.645800E-02 |
| N0-vs-N1 |
9.394200E-01 |
| N0-vs-N2 |
7.943400E-01 |
| N1-vs-N2 |
8.301200E-01 |
|
|
